IScienceWriter (@isciencewriter) 's Twitter Profile
IScienceWriter

@isciencewriter

International Science Writer (ISW) creating and sharing up-to-the-minute news about #lifescience, #biotech and #pharma industries.

ID: 469324230

linkhttp://www.internationalsciencewriter.com calendar_today20-01-2012 13:39:56

18,18K Tweet

5,5K Takipçi

3,3K Takip Edilen

Sartorius (@sartoriusglobal) 's Twitter Profile Photo

Our vaccine experts reflect on the lessons learned following the industry’s yearlong response to the COVID-19 pandemic. Watch the video to hear Amélie Boulais and Piergiuseppe Nestola answer important questions about current and future vaccine development. ow.ly/iTYD50EoqRw

Sartorius (@sartoriusglobal) 's Twitter Profile Photo

Are you finding scaling-up and scaling-down between bioreactors a challenge? Then register for our scaling webinar on September 14 to gain insights from our experts into simplifying and de-risking the process. ow.ly/BhO450FYAd1

Are you finding scaling-up and scaling-down between bioreactors a challenge? Then register for our scaling webinar on September 14 to gain insights from our experts into simplifying and de-risking the process. ow.ly/BhO450FYAd1
IScienceWriter (@isciencewriter) 's Twitter Profile Photo

Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .Sartorius #webinar on September 14th view6.workcast.net/register?cpak=… #biotech pic.x.com/CciXANf7bv

IScienceWriter (@isciencewriter) 's Twitter Profile Photo

Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .Sartorius #webinar on September 14th view6.workcast.net/register?cpak=… #biotech pic.x.com/CciXANf7bv

IScienceWriter (@isciencewriter) 's Twitter Profile Photo

Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .Sartorius #webinar on September 14th view6.workcast.net/register?cpak=… #bioreactor pic.x.com/CciXANf7bv

IScienceWriter (@isciencewriter) 's Twitter Profile Photo

Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .Sartorius #webinar on September 14th view6.workcast.net/register?cpak=… #pharma pic.x.com/CciXANf7bv

IScienceWriter (@isciencewriter) 's Twitter Profile Photo

Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .Sartorius #webinar on September 14th view6.workcast.net/register?cpak=… #biopharma pic.x.com/CciXANf7bv

IScienceWriter (@isciencewriter) 's Twitter Profile Photo

Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .Sartorius #webinar on September 14th view6.workcast.net/register?cpak=… #bioprocessing pic.x.com/CciXANf7bv

IScienceWriter (@isciencewriter) 's Twitter Profile Photo

Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .Sartorius #webinar on September 14th view6.workcast.net/register?cpak=… #vaccines pic.x.com/CciXANf7bv

BioTechniques (@mybiotechniques) 's Twitter Profile Photo

A huge congratulations to Steve Rees for receiving @ELRIG_UK’s Inaugural Lifetime Achievement Award today at #DrugDiscovery2021, in recognition of his significant contribution to the #lifescience sector.

A huge congratulations to Steve Rees for receiving @ELRIG_UK’s Inaugural Lifetime Achievement Award today at #DrugDiscovery2021, in recognition of his significant contribution to the #lifescience sector.
Rob Boyd, Esq (@avonandsomerrob) 's Twitter Profile Photo

20 months after the 40,000 trial subjects were given the Oxford/AZ vaccine, no loss of protection from serious illness has been observed in under 70s who had 2 doses of AstraZeneca almost 2 years ago - Sarah Gilbert. AZ designed as a 2 dose vaccine, not 3, not boost-dependent.

20 months after the 40,000 trial subjects were given the Oxford/AZ vaccine, no loss of protection from serious illness has been observed in under 70s who had 2 doses of AstraZeneca almost 2 years ago - Sarah Gilbert. 

AZ designed as a 2 dose vaccine, not 3, not boost-dependent.
Dr. Simon Goddek (@goddeketal) 's Twitter Profile Photo

𝗦𝘂𝗿𝗽𝗿𝗶𝘀𝗲, 𝘀𝘂𝗿𝗽𝗿𝗶𝘀𝗲! "Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of population-based controls (p<0.0001)." (bit.ly/3Wr4srL) And frankly speaking, I doubt that anybody would get ill at all with 25(OH)D levels above 50 ng/mL.

𝗦𝘂𝗿𝗽𝗿𝗶𝘀𝗲, 𝘀𝘂𝗿𝗽𝗿𝗶𝘀𝗲!

"Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of population-based controls (p&lt;0.0001)." (bit.ly/3Wr4srL)

And frankly speaking, I doubt that anybody would get ill at all with 25(OH)D levels above 50 ng/mL.
ProductLife Group (@plg_eu) 's Twitter Profile Photo

Check out Asif R. 's DSI - DS InPharmatics, a PLG company Business Development Director's insightful interview with CPHI Online on supply chain issues, data analytics, and their impact on the regulatory landscape in the life sciences industry. Read more: lnkd.in/dG4k3VBq

Check out Asif R. 's DSI - DS InPharmatics, a PLG company Business Development Director's insightful interview with CPHI Online on supply chain issues, data analytics, and their impact on the regulatory landscape in the life sciences industry. Read more: lnkd.in/dG4k3VBq
IScienceWriter (@isciencewriter) 's Twitter Profile Photo

NEW OPTURA®PALM® Handheld Contactless Biomass Sensor from Aber Offers Accurate Cell Density Measurement in Seconds Without Sampling. Technology is used across biopharmaceutical, brewing, biofuel industries etc biotechnewswire.ai/202408082567/n…